SpIntellx
SpIntellx turns tumor biopsy images into actionable biomarkers to improve patient selection and outcomes in cancer immunotherapy. The company offers a Spatially Intelligent Platform that applies spatial analytics, explainable AI, and deep learning to histopathology and tissue-based multi-omic data to identify cell types, states, and intercellular communications. Its end-to-end B2B platform supports tissue QC, advanced spatial analysis, biomarker discovery, and translational deployment for pharmaceutical researchers, translational scientists, and clinical teams. The platform integrates with translational workflows and targets applications across drug discovery, clinical trial biomarker design, and companion diagnostic development.
SpIntellx
SpIntellx turns tumor biopsy images into actionable biomarkers to improve patient selection and outcomes in cancer immunotherapy. The company offers a Spatially Intelligent Platform that applies spatial analytics, explainable AI, and deep learning to histopathology and tissue-based multi-omic data to identify cell types, states, and intercellular communications. Its end-to-end B2B platform supports tissue QC, advanced spatial analysis, biomarker discovery, and translational deployment for pharmaceutical researchers, translational scientists, and clinical teams. The platform integrates with translational workflows and targets applications across drug discovery, clinical trial biomarker design, and companion diagnostic development.